Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, China.
Postgraduate College, China Medical University, Shenyang, China.
Front Public Health. 2022 Mar 10;10:851295. doi: 10.3389/fpubh.2022.851295. eCollection 2022.
Active and severe ulcerative colitis (UC) and non-response to 5-aminosalicylic acid (5-ASA) are related to poor outcomes and should be accurately identified. Several integrated inflammatory indexes are potentially useful to assess the disease severity in patients with acute or critical diseases but are underexplored in patients with UC.
Patients with UC consecutively admitted to our hospital between January 2015 and December 2020 were retrospectively grouped according to the activity and severity of UC and response to 5-ASA. The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), neutrophil-to-platelet ratio (NPR), platelet-to-albumin ratio (PAR), C-reactive protein-to-albumin ratio (CAR), and C-reactive protein-to-lymphocyte ratio (CLR) were calculated. The areas under receiver operating characteristic curves (AUC) were calculated.
Overall, 187 patients with UC were included, of whom 151 were active, 55 were severe, and 14 were unresponsive to 5-ASA. The active UC group had significantly higher NLR, PLR, SII, and PAR levels. SII had the greatest predictive accuracy for active UC, followed by PLR, PAR, and NLR (AUC = 0.647, 0.641, 0.634, and 0.626). The severe UC group had significantly higher NLR, PLR, SII, PAR, CAR, and CLR levels. CLR had the greatest predictive accuracy for severe UC, followed by CAR, PLR, SII, NLR, and PAR (AUC = 0.732, 0.714, 0.693, 0.669, 0.646, and 0.63). The non-response to the 5-ASA group had significantly higher CAR and CLR levels. CAR had a greater predictive accuracy for non-response to 5-ASA than CLR (AUC = 0.781 and 0.759).
SII, CLR, and CAR may be useful for assessing the severity and progression of UC, but remain not optimal.
活动期和重度溃疡性结肠炎(UC)以及对 5-氨基水杨酸(5-ASA)无反应与不良预后相关,应准确识别。一些综合炎症指标可能有助于评估急性或危重病患者的疾病严重程度,但在 UC 患者中研究较少。
回顾性分析 2015 年 1 月至 2020 年 12 月我院连续收治的 UC 患者,根据 UC 活动度和严重程度以及对 5-ASA 的反应进行分组。计算中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、全身免疫炎症指数(SII)、中性粒细胞与血小板比值(NPR)、血小板与白蛋白比值(PAR)、C 反应蛋白与白蛋白比值(CAR)和 C 反应蛋白与淋巴细胞比值(CLR)。计算受试者工作特征曲线(ROC)下面积(AUC)。
共纳入 187 例 UC 患者,其中活动期 151 例,重度 55 例,5-ASA 无反应 14 例。活动期 UC 组 NLR、PLR、SII 和 PAR 水平显著升高。SII 对活动期 UC 的预测准确性最高,其次是 PLR、PAR 和 NLR(AUC=0.647、0.641、0.634 和 0.626)。重度 UC 组 NLR、PLR、SII、PAR、CAR 和 CLR 水平显著升高。CLR 对重度 UC 的预测准确性最高,其次是 CAR、PLR、SII、NLR 和 PAR(AUC=0.732、0.714、0.693、0.669、0.646 和 0.63)。5-ASA 无反应组 CAR 和 CLR 水平显著升高。CAR 对 5-ASA 无反应的预测准确性高于 CLR(AUC=0.781 和 0.759)。
SII、CLR 和 CAR 可能有助于评估 UC 的严重程度和进展,但仍不理想。